Catalyst Wire Dossier Catalyst Wire Dossier

CAVERJECT

ALPROSTADIL · Pharmacia & Upjohn Company LLC
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for CAVERJECT, covering 2012-03-28 to 2022-12-23. Get the full timeline:

Most recent: FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)

See pricing